PubRank

A H Enk

Author PubWeight™ 57.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001 7.46
2 Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000 6.45
3 Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997 5.48
4 Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997 4.65
5 Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 1999 2.47
6 Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001 2.20
7 Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 1998 1.77
8 A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer 2001 1.52
9 Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction. Br J Dermatol 2011 1.51
10 Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T cells. J Immunol 1997 1.46
11 Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 1997 1.30
12 IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J Immunol 1995 1.26
13 Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997 1.22
14 Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity. Gene Ther 2000 1.16
15 Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch Dermatol Res 1996 1.10
16 Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet 1997 0.99
17 Inhibition of human allergic T-cell responses by IL-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol 2001 0.98
18 Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J Invest Dermatol 2000 0.96
19 Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity. J Gene Med 2000 0.96
20 Dendritic cells: key cells for the induction of regulatory T cells? Curr Top Microbiol Immunol 2005 0.95
21 Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur J Immunol 1998 0.94
22 Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. J Invest Dermatol 2000 0.88
23 Malignant syphilis with ocular involvement and organism-depleted lesions. Clin Infect Dis 2009 0.87
24 Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins. Arch Dermatol Res 2000 0.87
25 Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy. Gene Ther 2003 0.87
26 Identification and induction of human keratinocyte-derived IL-12. J Clin Invest 1994 0.85
27 Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases. Gene Ther 2000 0.81
28 Signals involved in the early TH1/TH2 polarization of an immune response depending on the type of antigen. J Allergy Clin Immunol 1999 0.80
29 Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells. Arch Dermatol Res 2000 0.79
30 Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers. J Immunol 1998 0.79
31 [Immunology of allergic contact dermatitis]. Hautarzt 2009 0.77
32 Is cytokine expression responsible for differences between allergens and irritants? Am J Contact Dermat 1996 0.77
33 Modulation of contact sensitivity responses by bacterial superantigen. J Invest Dermatol 1995 0.77
34 CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy. Cancer Gene Ther 2000 0.77
35 Epidermal cells enhance interleukin 4 and immunoglobulin E production after stimulation with protein allergen. J Invest Dermatol 1996 0.75
36 Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivo. Immunology 1998 0.75
37 Early events in contact sensitivity. Adv Exp Med Biol 1995 0.75
38 Human keratinocyte-derived IL-12 affects LC-induced allogeneic T-cell responses. Adv Exp Med Biol 1995 0.75
39 Prevention and reversal of superantigen-induced anergy by contact allergen exposure. Exp Dermatol 1995 0.75
40 Cellular and molecular mechanisms in the induction phase of contact sensitivity. Int Arch Allergy Immunol 1995 0.75
41 Heat-stable antigen is expressed by murine keratinocytes and delivers costimulatory signals in T-cell activation. Exp Dermatol 1995 0.75
42 [Experiences with therapy of stage IV metastatic malignant melanoma with "Legha Protocol" polychemoimmunotherapy]. Hautarzt 2002 0.75
43 Allergen-specific immune deviation from a TH2 to a TH1 response induced by dendritic cells and collagen type I. J Allergy Clin Immunol 1999 0.75